Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This information is for patients having gynaecology surgery who may also need bowel (colorectal) surgery as part of their cancer treatment.
-
A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.
-
One of the FOIA Code of Practice requirements is for public authorities to publish more information about their performance in handling FOIA requests.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
Information for patients from overseas visiting UCLH hospitals.
-
This information is for patients receiving steroids for immunotherapy toxicity.
File results
-
FOI/2021/0732 - Policy for maternity partners
-
FOI/2021/0734 - Sexual harassment against catering staff
-
FOI/2021/0749 - Private contractors
-
FOI/2021/0751 - TB Find and Treat programme
-
FOI/2022/0002 - Patient Portal / Patient Access Portal system
-
FOI/2022/0007 - Priory Group services at the Trust
-
FOI/2022/0008 - Functional electrical stimulation devices
-
FOI/2022/0012 - Paediatric antibiotic guideline
-
FOI/2022/0014 - Water treatment equipment in sterile services department
-
FOI/2022/0042 - Thermometers used at Trust